Showing results (1-10 of 61) with videos related to
Sort By:
Pageof 7
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|April 2, 2010
Effect of cetuximab treatment in squamous cell carcinomasMarika NestorJournal of Molecular Recognition : JMR|April 29, 2008
Characterization of 111In and 177Lu-labeled antibodies binding to CD44v6 using a novel automated radioimmunoassayMarika Nestor, Karl Andersson, Hans LundqvistPharmaceutical Research|March 15, 2003
Tumor-cell targeted epiderimal growth factor liposomes loaded with boronated acridine: uptake and processingErika Bohl Kullberg, Marika Nestor, Lars GeddaNuclear Medicine and Biology|January 12, 2011
Effect of cetuximab in combination with alpha-radioimmunotherapy in cultured squamous cell carcinomasMarika Nestor, Magnus Sundström, Matti Anniko, et al.Nuclear Medicine and Biology|December 3, 2013
Choice of labeling and cell line influences interactions between the Fab fragment AbD15179 and its target antigen CD44v6Jonas Stenberg, Diana Spiegelberg, Hampus Karlsson, et al.Metabolites|April 3, 2021
Improved Sensitivity in Hydrophilic Interaction Liquid Chromatography-Electrospray-Mass Spectrometry after Removal of Sodium and Potassium Ions from Biological SamplesIda Erngren, Marika Nestor, Curt Pettersson, et al.International Journal of Oncology|October 23, 2019
The HSP90 inhibitor onalespib potentiates 177Lu‑DOTATATE therapy in neuroendocrine tumor cellsSara Lundsten, Diana Spiegelberg, Bo Stenerlöw, et al.Biotechnology and Applied Biochemistry|April 17, 2013
Selection and in vitro characterization of human CD44v6-binding antibody fragmentsJohan Nilvebrant, Gamze Kuku, Hanna Björkelund, et al.European Journal of Nuclear Medicine and Molecular Imaging|January 9, 2020
The radiosensitizer Onalespib increases complete remission in 177Lu-DOTATATE-treated mice bearing neuroendocrine tumor xenograftsSara Lundsten, Diana Spiegelberg, Nakul R Raval, et al.Nuclear Medicine and Biology|December 26, 2015
A real-time in vitro assay as a potential predictor of in vivo tumor imaging propertiesDiana Spiegelberg, Jonas Stenberg, Anna-Karin Haylock, et al.Pageof 7